Study of Percutaneous Stent Placement with Iodine-125 Seed Strand for Malignant Biliary Obstruction
Purpose To evaluate the effectiveness and safety of simultaneous placement of a self-expandable metallic stents (SEMS) and iodine-125 seed strand in the management of malignant obstructive jaundice (MOJ). Materials and Methods This study included 132 patients with MOJ treated from November 2015 to O...
Gespeichert in:
| Veröffentlicht in: | Cardiovascular and interventional radiology 2019-02, Vol.42 (2), p.268-275 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 275 |
|---|---|
| container_issue | 2 |
| container_start_page | 268 |
| container_title | Cardiovascular and interventional radiology |
| container_volume | 42 |
| creator | Zhou, Wei-Zhong Fu, Yong-Meng Yang, Zheng-Qiang Shi, Hai-Bin Liu, Sheng Xia, Jin-Guo Zhou, Chun-Gao |
| description | Purpose
To evaluate the effectiveness and safety of simultaneous placement of a self-expandable metallic stents (SEMS) and iodine-125 seed strand in the management of malignant obstructive jaundice (MOJ).
Materials and Methods
This study included 132 patients with MOJ treated from November 2015 to October 2017. Forty-five patients underwent insertion of SEMS with iodine-125 seed strands (Seeds group); the remaining 87 patients underwent SEMS placement alone (Control group). Technical success was defined as accurate, successful deployment of SEMS with or without iodine-125 seed strand; clinical success was defined as 20% reduction in serum bilirubin within 1 week after the procedure, compared with baseline. Complications, duration of primary stent patency, and overall survival were evaluated.
Results
Technical success was achieved in all patients in both groups. In the Seeds group, an average of 14 seeds (range 8–22) were implanted in the bile duct as a strand. Clinical success rates were similar between the groups (Seeds group, 93.3%; Control group, 95.4%). Major complications occurred in only one patient, in the Control group. The median period of primary stent patency was significantly longer in the Seeds group (194 days) than in the Control group (86 days;
P
= 0.049). The median overall survival was also significantly longer in the Seeds group (194 days) than in the Control group (96 days;
P
= 0.031).
Conclusion
SEMS combined with iodine-125 seed strands is effective and safe in the management of MOJ and can improve stent patency and patient survival. |
| doi_str_mv | 10.1007/s00270-018-2117-7 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_osti_scitechconnect_22953146</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2139826722</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-3dd5ff58c0c96857a6b3b449fed4c5c7ce961108d9a9f23743cffd97e1c6b23d3</originalsourceid><addsrcrecordid>eNp1kU9rFjEQh4NY7NvqB_AiC168rJ1JNpvNUYvaQksLr4K3sJs_bcq-SU2ySL9987K1PXnKQJ75DTMPIe8RPiOAOMkAVEALOLQUUbTiFdlgx2gLQ__7NdkAiq5FzvGQHOV8B4B8oPwNOWTAocdebojelsU8NNE11zbppYzBxiU322JDaa7nUdvdvvrry21zHo0PtkXKm621pkJpDKZxMTWX4-xvwljJr372Y3porqZc0qKLj-EtOXDjnO27p_eY_Pr-7efpWXtx9eP89MtFqzuA0jJjuHN80KBlP3Ax9hObuk46azrNtdBW9ogwGDlKR5nomHbOSGFR9xNlhh2Tj2tuzMWrrH2x-lbHEKwuilLJGXZ9pT6t1H2Kfxabi9r5rO08r6srip0EytkAL4HP6F1cUqg7VIrJgfaC0krhSukUc07Wqfvkd_UGCkHtPanVk6qe1N6TErXnw1PyMu2see74J6YCdAVy_Qo3Nr2M_n_qIzB6nEs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2139826722</pqid></control><display><type>article</type><title>Study of Percutaneous Stent Placement with Iodine-125 Seed Strand for Malignant Biliary Obstruction</title><source>Springer Online Journals Complete</source><creator>Zhou, Wei-Zhong ; Fu, Yong-Meng ; Yang, Zheng-Qiang ; Shi, Hai-Bin ; Liu, Sheng ; Xia, Jin-Guo ; Zhou, Chun-Gao</creator><creatorcontrib>Zhou, Wei-Zhong ; Fu, Yong-Meng ; Yang, Zheng-Qiang ; Shi, Hai-Bin ; Liu, Sheng ; Xia, Jin-Guo ; Zhou, Chun-Gao</creatorcontrib><description>Purpose
To evaluate the effectiveness and safety of simultaneous placement of a self-expandable metallic stents (SEMS) and iodine-125 seed strand in the management of malignant obstructive jaundice (MOJ).
Materials and Methods
This study included 132 patients with MOJ treated from November 2015 to October 2017. Forty-five patients underwent insertion of SEMS with iodine-125 seed strands (Seeds group); the remaining 87 patients underwent SEMS placement alone (Control group). Technical success was defined as accurate, successful deployment of SEMS with or without iodine-125 seed strand; clinical success was defined as 20% reduction in serum bilirubin within 1 week after the procedure, compared with baseline. Complications, duration of primary stent patency, and overall survival were evaluated.
Results
Technical success was achieved in all patients in both groups. In the Seeds group, an average of 14 seeds (range 8–22) were implanted in the bile duct as a strand. Clinical success rates were similar between the groups (Seeds group, 93.3%; Control group, 95.4%). Major complications occurred in only one patient, in the Control group. The median period of primary stent patency was significantly longer in the Seeds group (194 days) than in the Control group (86 days;
P
= 0.049). The median overall survival was also significantly longer in the Seeds group (194 days) than in the Control group (96 days;
P
= 0.031).
Conclusion
SEMS combined with iodine-125 seed strands is effective and safe in the management of MOJ and can improve stent patency and patient survival.</description><identifier>ISSN: 0174-1551</identifier><identifier>EISSN: 1432-086X</identifier><identifier>DOI: 10.1007/s00270-018-2117-7</identifier><identifier>PMID: 30506169</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Bile ducts ; BILIARY TRACT ; BILIRUBIN ; Cardiology ; Clinical Investigation ; COMPARATIVE EVALUATIONS ; Complications ; FLUOROSCOPY ; Imaging ; Implants ; Iodine ; IODINE 125 ; Iodine isotopes ; Iodine radioisotopes ; JAUNDICE ; Medicine ; Medicine & Public Health ; MULTIVARIATE ANALYSIS ; Non-Vascular Interventions ; Nuclear Medicine ; PATIENTS ; Placement ; RADIATION SOURCE IMPLANTS ; Radiology ; RADIOLOGY AND NUCLEAR MEDICINE ; Seeds ; Stents ; Strands ; Success ; Surgical implants ; Survival ; Ultrasound</subject><ispartof>Cardiovascular and interventional radiology, 2019-02, Vol.42 (2), p.268-275</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2018</rights><rights>CardioVascular and Interventional Radiology is a copyright of Springer, (2018). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-3dd5ff58c0c96857a6b3b449fed4c5c7ce961108d9a9f23743cffd97e1c6b23d3</citedby><cites>FETCH-LOGICAL-c400t-3dd5ff58c0c96857a6b3b449fed4c5c7ce961108d9a9f23743cffd97e1c6b23d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00270-018-2117-7$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00270-018-2117-7$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,315,781,785,886,27929,27930,41493,42562,51324</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30506169$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/22953146$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhou, Wei-Zhong</creatorcontrib><creatorcontrib>Fu, Yong-Meng</creatorcontrib><creatorcontrib>Yang, Zheng-Qiang</creatorcontrib><creatorcontrib>Shi, Hai-Bin</creatorcontrib><creatorcontrib>Liu, Sheng</creatorcontrib><creatorcontrib>Xia, Jin-Guo</creatorcontrib><creatorcontrib>Zhou, Chun-Gao</creatorcontrib><title>Study of Percutaneous Stent Placement with Iodine-125 Seed Strand for Malignant Biliary Obstruction</title><title>Cardiovascular and interventional radiology</title><addtitle>Cardiovasc Intervent Radiol</addtitle><addtitle>Cardiovasc Intervent Radiol</addtitle><description>Purpose
To evaluate the effectiveness and safety of simultaneous placement of a self-expandable metallic stents (SEMS) and iodine-125 seed strand in the management of malignant obstructive jaundice (MOJ).
Materials and Methods
This study included 132 patients with MOJ treated from November 2015 to October 2017. Forty-five patients underwent insertion of SEMS with iodine-125 seed strands (Seeds group); the remaining 87 patients underwent SEMS placement alone (Control group). Technical success was defined as accurate, successful deployment of SEMS with or without iodine-125 seed strand; clinical success was defined as 20% reduction in serum bilirubin within 1 week after the procedure, compared with baseline. Complications, duration of primary stent patency, and overall survival were evaluated.
Results
Technical success was achieved in all patients in both groups. In the Seeds group, an average of 14 seeds (range 8–22) were implanted in the bile duct as a strand. Clinical success rates were similar between the groups (Seeds group, 93.3%; Control group, 95.4%). Major complications occurred in only one patient, in the Control group. The median period of primary stent patency was significantly longer in the Seeds group (194 days) than in the Control group (86 days;
P
= 0.049). The median overall survival was also significantly longer in the Seeds group (194 days) than in the Control group (96 days;
P
= 0.031).
Conclusion
SEMS combined with iodine-125 seed strands is effective and safe in the management of MOJ and can improve stent patency and patient survival.</description><subject>Bile ducts</subject><subject>BILIARY TRACT</subject><subject>BILIRUBIN</subject><subject>Cardiology</subject><subject>Clinical Investigation</subject><subject>COMPARATIVE EVALUATIONS</subject><subject>Complications</subject><subject>FLUOROSCOPY</subject><subject>Imaging</subject><subject>Implants</subject><subject>Iodine</subject><subject>IODINE 125</subject><subject>Iodine isotopes</subject><subject>Iodine radioisotopes</subject><subject>JAUNDICE</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>MULTIVARIATE ANALYSIS</subject><subject>Non-Vascular Interventions</subject><subject>Nuclear Medicine</subject><subject>PATIENTS</subject><subject>Placement</subject><subject>RADIATION SOURCE IMPLANTS</subject><subject>Radiology</subject><subject>RADIOLOGY AND NUCLEAR MEDICINE</subject><subject>Seeds</subject><subject>Stents</subject><subject>Strands</subject><subject>Success</subject><subject>Surgical implants</subject><subject>Survival</subject><subject>Ultrasound</subject><issn>0174-1551</issn><issn>1432-086X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kU9rFjEQh4NY7NvqB_AiC168rJ1JNpvNUYvaQksLr4K3sJs_bcq-SU2ySL9987K1PXnKQJ75DTMPIe8RPiOAOMkAVEALOLQUUbTiFdlgx2gLQ__7NdkAiq5FzvGQHOV8B4B8oPwNOWTAocdebojelsU8NNE11zbppYzBxiU322JDaa7nUdvdvvrry21zHo0PtkXKm621pkJpDKZxMTWX4-xvwljJr372Y3porqZc0qKLj-EtOXDjnO27p_eY_Pr-7efpWXtx9eP89MtFqzuA0jJjuHN80KBlP3Ax9hObuk46azrNtdBW9ogwGDlKR5nomHbOSGFR9xNlhh2Tj2tuzMWrrH2x-lbHEKwuilLJGXZ9pT6t1H2Kfxabi9r5rO08r6srip0EytkAL4HP6F1cUqg7VIrJgfaC0krhSukUc07Wqfvkd_UGCkHtPanVk6qe1N6TErXnw1PyMu2see74J6YCdAVy_Qo3Nr2M_n_qIzB6nEs</recordid><startdate>20190201</startdate><enddate>20190201</enddate><creator>Zhou, Wei-Zhong</creator><creator>Fu, Yong-Meng</creator><creator>Yang, Zheng-Qiang</creator><creator>Shi, Hai-Bin</creator><creator>Liu, Sheng</creator><creator>Xia, Jin-Guo</creator><creator>Zhou, Chun-Gao</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>OTOTI</scope></search><sort><creationdate>20190201</creationdate><title>Study of Percutaneous Stent Placement with Iodine-125 Seed Strand for Malignant Biliary Obstruction</title><author>Zhou, Wei-Zhong ; Fu, Yong-Meng ; Yang, Zheng-Qiang ; Shi, Hai-Bin ; Liu, Sheng ; Xia, Jin-Guo ; Zhou, Chun-Gao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-3dd5ff58c0c96857a6b3b449fed4c5c7ce961108d9a9f23743cffd97e1c6b23d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Bile ducts</topic><topic>BILIARY TRACT</topic><topic>BILIRUBIN</topic><topic>Cardiology</topic><topic>Clinical Investigation</topic><topic>COMPARATIVE EVALUATIONS</topic><topic>Complications</topic><topic>FLUOROSCOPY</topic><topic>Imaging</topic><topic>Implants</topic><topic>Iodine</topic><topic>IODINE 125</topic><topic>Iodine isotopes</topic><topic>Iodine radioisotopes</topic><topic>JAUNDICE</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>MULTIVARIATE ANALYSIS</topic><topic>Non-Vascular Interventions</topic><topic>Nuclear Medicine</topic><topic>PATIENTS</topic><topic>Placement</topic><topic>RADIATION SOURCE IMPLANTS</topic><topic>Radiology</topic><topic>RADIOLOGY AND NUCLEAR MEDICINE</topic><topic>Seeds</topic><topic>Stents</topic><topic>Strands</topic><topic>Success</topic><topic>Surgical implants</topic><topic>Survival</topic><topic>Ultrasound</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhou, Wei-Zhong</creatorcontrib><creatorcontrib>Fu, Yong-Meng</creatorcontrib><creatorcontrib>Yang, Zheng-Qiang</creatorcontrib><creatorcontrib>Shi, Hai-Bin</creatorcontrib><creatorcontrib>Liu, Sheng</creatorcontrib><creatorcontrib>Xia, Jin-Guo</creatorcontrib><creatorcontrib>Zhou, Chun-Gao</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>OSTI.GOV</collection><jtitle>Cardiovascular and interventional radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhou, Wei-Zhong</au><au>Fu, Yong-Meng</au><au>Yang, Zheng-Qiang</au><au>Shi, Hai-Bin</au><au>Liu, Sheng</au><au>Xia, Jin-Guo</au><au>Zhou, Chun-Gao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Study of Percutaneous Stent Placement with Iodine-125 Seed Strand for Malignant Biliary Obstruction</atitle><jtitle>Cardiovascular and interventional radiology</jtitle><stitle>Cardiovasc Intervent Radiol</stitle><addtitle>Cardiovasc Intervent Radiol</addtitle><date>2019-02-01</date><risdate>2019</risdate><volume>42</volume><issue>2</issue><spage>268</spage><epage>275</epage><pages>268-275</pages><issn>0174-1551</issn><eissn>1432-086X</eissn><abstract>Purpose
To evaluate the effectiveness and safety of simultaneous placement of a self-expandable metallic stents (SEMS) and iodine-125 seed strand in the management of malignant obstructive jaundice (MOJ).
Materials and Methods
This study included 132 patients with MOJ treated from November 2015 to October 2017. Forty-five patients underwent insertion of SEMS with iodine-125 seed strands (Seeds group); the remaining 87 patients underwent SEMS placement alone (Control group). Technical success was defined as accurate, successful deployment of SEMS with or without iodine-125 seed strand; clinical success was defined as 20% reduction in serum bilirubin within 1 week after the procedure, compared with baseline. Complications, duration of primary stent patency, and overall survival were evaluated.
Results
Technical success was achieved in all patients in both groups. In the Seeds group, an average of 14 seeds (range 8–22) were implanted in the bile duct as a strand. Clinical success rates were similar between the groups (Seeds group, 93.3%; Control group, 95.4%). Major complications occurred in only one patient, in the Control group. The median period of primary stent patency was significantly longer in the Seeds group (194 days) than in the Control group (86 days;
P
= 0.049). The median overall survival was also significantly longer in the Seeds group (194 days) than in the Control group (96 days;
P
= 0.031).
Conclusion
SEMS combined with iodine-125 seed strands is effective and safe in the management of MOJ and can improve stent patency and patient survival.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>30506169</pmid><doi>10.1007/s00270-018-2117-7</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0174-1551 |
| ispartof | Cardiovascular and interventional radiology, 2019-02, Vol.42 (2), p.268-275 |
| issn | 0174-1551 1432-086X |
| language | eng |
| recordid | cdi_osti_scitechconnect_22953146 |
| source | Springer Online Journals Complete |
| subjects | Bile ducts BILIARY TRACT BILIRUBIN Cardiology Clinical Investigation COMPARATIVE EVALUATIONS Complications FLUOROSCOPY Imaging Implants Iodine IODINE 125 Iodine isotopes Iodine radioisotopes JAUNDICE Medicine Medicine & Public Health MULTIVARIATE ANALYSIS Non-Vascular Interventions Nuclear Medicine PATIENTS Placement RADIATION SOURCE IMPLANTS Radiology RADIOLOGY AND NUCLEAR MEDICINE Seeds Stents Strands Success Surgical implants Survival Ultrasound |
| title | Study of Percutaneous Stent Placement with Iodine-125 Seed Strand for Malignant Biliary Obstruction |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T08%3A55%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Study%20of%20Percutaneous%20Stent%20Placement%20with%20Iodine-125%20Seed%20Strand%20for%20Malignant%20Biliary%20Obstruction&rft.jtitle=Cardiovascular%20and%20interventional%20radiology&rft.au=Zhou,%20Wei-Zhong&rft.date=2019-02-01&rft.volume=42&rft.issue=2&rft.spage=268&rft.epage=275&rft.pages=268-275&rft.issn=0174-1551&rft.eissn=1432-086X&rft_id=info:doi/10.1007/s00270-018-2117-7&rft_dat=%3Cproquest_osti_%3E2139826722%3C/proquest_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2139826722&rft_id=info:pmid/30506169&rfr_iscdi=true |